REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 136 filers reported holding REVANCE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $371,000 | +64.9% | 15,200 | 0.0% | 0.05% | +35.3% |
| Q1 2020 | $225,000 | -87.8% | 15,200 | -86.6% | 0.03% | -71.9% |
| Q4 2019 | $1,842,000 | +165.4% | 113,544 | +112.6% | 0.12% | +44.0% |
| Q3 2019 | $694,000 | +1.6% | 53,400 | +1.4% | 0.08% | -1.2% |
| Q2 2019 | $683,000 | -23.5% | 52,672 | -7.1% | 0.08% | -30.3% |
| Q1 2019 | $893,000 | -21.7% | 56,672 | 0.0% | 0.12% | -23.3% |
| Q4 2018 | $1,141,000 | -21.7% | 56,672 | -3.4% | 0.16% | -23.2% |
| Q3 2018 | $1,458,000 | +60.4% | 58,672 | +77.3% | 0.21% | +71.1% |
| Q2 2018 | $909,000 | +224.6% | 33,100 | +263.7% | 0.12% | +236.1% |
| Q1 2018 | $280,000 | -13.8% | 9,100 | 0.0% | 0.04% | -32.1% |
| Q4 2017 | $325,000 | – | 9,100 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,228,609 | $59,972,145 | 5.67% |
| Essex Woodlands Management, Inc. | 457,085 | $5,242,765 | 4.62% |
| Ghost Tree Capital, LLC | 350,000 | $4,014,500 | 1.32% |
| AlphaCentric Advisors LLC | 190,000 | $2,179,300 | 1.24% |
| Sio Capital Management, LLC | 342,477 | $3,928,211 | 1.22% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 288,726 | $3,308,800 | 1.12% |
| Rubric Capital Management LP | 1,600,000 | $18,352,000 | 0.69% |
| RICE HALL JAMES & ASSOCIATES, LLC | 683,937 | $7,844,757 | 0.50% |
| Rhenman & Partners Asset Management AB | 361,679 | $4,148,458 | 0.45% |
| Polar Capital Holdings Plc | 4,160,311 | $47,718,767 | 0.35% |